Enhancing ascitic fungal infection diagnosis through next-generation sequencing: a pilot study in surgical ICU

Sara Posadas-Cantera1, Negin Mehrbarzin1, Simon Wetzel1,2

  • 1Institute of Medical Microbiology and Hygiene, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Abstract

Insights

Next-generation sequencing (NGS) offers higher sensitivity for diagnosing fungal infections in ascitic fluid compared to traditional methods. This advanced technique aids in identifying pathogens, improving patient outcomes in intensive care settings.

Area of Science:

  • Medical Microbiology
  • Genomics
  • Critical Care Medicine

Background:

  • Ascites, a critical condition linked to liver cirrhosis or bowel perforation, is prone to fungal infections.
  • Fungal infections in ascites significantly increase mortality, particularly in intensive care units (ICUs).
  • Current microbiological diagnostics for fungal pathogens in ascitic fluid lack sensitivity, necessitating improved methods.

Purpose of the Study:

  • To evaluate the efficacy of next-generation sequencing (NGS) for identifying fungal pathogens in ascitic fluid.
  • To compare the diagnostic performance of NGS with traditional culture-based methods.

Main Methods:

  • Prospective collection of 50 ascitic fluid samples from ICU patients with suspected infection.
  • Standard microbiological testing (culture) and fungal DNA isolation followed by NGS analysis.
  • Analysis of the Internal Transcribed Spacer 2 (ITS2) region for fungal identification.

Main Results:

  • NGS identified fungal pathogens in 19 out of 50 samples, significantly more than culture alone.
  • Culture detected Candida spp. in only five samples.
  • Fungal DNA detection by sequencing correlated with poorer patient outcomes and specific clinical parameters.

Conclusions:

  • NGS demonstrates superior sensitivity for diagnosing fungal infections in ascitic fluid compared to standard cultures.
  • This advanced diagnostic approach holds promise for guiding antifungal therapy and improving critical care patient outcomes.
  • Standardization of NGS workflows and result interpretation is crucial for clinical implementation.